Drug Formulation with Cyclodextrins
Velesco is a niche contract research organization (CRO) specializing in early phase drug development. One of our core competencies is formulation of compounds for early toxicology studies. We take a targeted, scientific approach to pharmaceutical formulation.
One of our tools for formulation of poorly soluble early stage compounds is the family of cyclodextrins.
To learn more about how Velesco is utilizing cyclodextrins in early phase drug development, download our free whitepaper describing cyclodextrins and how they can be used as early stage solubilizers.
News and Events
Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group. Read the press release here.
CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!
2 new job postings! Careers
Velesco's work published
Outsourcing Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.